TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis

Wang, X., Zeldin, S., Shi, H., Zhu, C., Saito, Y., Corey, K. E., Osganian, S. A., Remotti, H. E., Verna, E. C., Pajvani, U. B., Schwabe, R. F., & Tabas, I. (2022). TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. Journal of Hepatology, 76(4), 910–920. https://doi.org/10.1016/j.jhep.2021.11.031
Authors:
Xiaobo Wang
Sharon Zeldin
Hongxue Shi
Changyu Zhu
Yoshinobu Saito
Kathleen E. Corey
Stephanie A. Osganian
Helen E. Remotti
Elizabeth C. Verna
Utpal B. Pajvani
Robert F. Schwabe
Ira Tabas
Affiliated Authors:
Xiaobo Wang
Sharon Zeldin
Hongxue Shi
Changyu Zhu
Yoshinobu Saito
Helen E. Remotti
Elizabeth C. Verna
Utpal B. Pajvani
Robert F. Schwabe
Ira Tabas
Columbia Affiliation:
Subjects:
Adaptor Proteins, Signal Transducing (MeSH)
Carcinoma, Hepatocellular (MeSH)
Liver Neoplasms (MeSH)
NADPH Oxidase 2 (MeSH)
Non-alcoholic Fatty Liver Disease (MeSH)
Author Keywords:
nox2/cybb
taz/wwtr1
hepatocellular carcinoma (hcc)
nonalcoholic steatohepatitis (nash)
oxidative dna damage
elink
Publication Type:
Article
Unique ID:
10.1016/j.jhep.2021.11.031
PMID:
34902531
DOI:
10.1016/j.jhep.2021.11.031
Journal:
Journal of Hepatology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: